Avosia Pharma Private Limited
About Avosia Pharma Private Limited
Data last updated:
Avosia Pharma Private Limited is a private limited company based in Bathinda, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 April 2023.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U46497PB2023PTC058130. Its GSTIN is 06AAYCA4970C1ZF (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jagjit Kumar and Neelam Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bathinda, Punjab.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.9 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹60,848 (net margin 0.3%) and EBITDA of ₹6.1 Lakh (EBITDA margin 3.2%).
As per MCA filings, the company has open charges of ₹1.1 Cr on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressF – 102 Industrial Growth Centre, Mansa Road, Bathinda, Punjab, India – 151001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Avosia Pharma Private Limited
The main business activity of Avosia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Avosia Pharma Private Limited FY 2025 filings available
Avosia Pharma Private Limited reported revenue of ₹1.9 Cr (up 247% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Avosia Pharma Private Limited
Revenue rose 247% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Avosia Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹6.1 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | ₹60,848 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Avosia Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 3.2% | •••• |
| Net Profit Margin | 0.3% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Avosia Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Avosia Pharma Private Limited
Avosia Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Phenomenon Nutritech Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 399.0% | •••• | Ahmedabad, Gujarat, India |
| Zenith Chemical Works Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Mumbai, Maharashtra, India |
| Rege Engredea Private Limited | ₹1.91 Cr (FY 2018) | •••• | •••• | •••• | Nalgonda, Telangana, India | |
| Kan India Realtors Private Limited | ₹1.91 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Thane, Maharashtra, India |
| Laurel Pharmaceuticals Pvt Ltd | ₹1.91 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Jalandhar, Punjab, India |
| Avosia Pharma Private Limited this company | ₹1.9 Cr (FY 2025) | •••• | •••• | 247.0% | •••• | Bathinda, Punjab, India |
| Morksons Pharmaceuticals (India) Private Limited | ₹1.9 Cr (FY 2020) | •••• | •••• | -51.0% | •••• | New Delhi, Delhi, India |
| Indo-Swiss Remedies Private Limited | ₹1.89 Cr (FY 2024) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Global Actives Private Limited | ₹1.89 Cr (FY 2025) | •••• | •••• | 458.0% | •••• | Bangalore, Karnataka, India |
| Dynamic Organic Life Sciences Private Limited | ₹1.89 Cr (FY 2016) | •••• | •••• | 25.0% | •••• | Pithampur, Madhya Pradesh, India |
| Argion Cosmed India Private Limited | ₹1.89 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Avosia Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Avosia Pharma Private Limited
Avosia Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelam Rani | Additional Director | 08 Dec 2023 | 2 Years 10 Months | Current |
| Jagjit Kumar | Director | 10 Apr 2023 | 3 Years 6 Months | Current |
Charges & Borrowings of Avosia Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2024 | Hdfc Bank Limited | ₹60 Lakh | Open |
| 20 Oct 2023 | Others | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Avosia Pharma Private Limited
Employment history and EPFO contributions of people linked to Avosia Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Avosia Pharma Private Limited
Avosia Pharma Private Limited has 3 board changes on record since 2023: 2 appointments and 1 cessation. The latest: Neelam Rani was appointed as Additional Director on 08 Dec 2023.
Credit Ratings, Litigation & Regulatory Alerts for Avosia Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Avosia Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Avosia Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Avosia Pharma Private Limited
Avosia Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAYCA4970C1ZF | Haryana | Active | 08 May 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Avosia Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avosia Pharma Private Limited
Avosia Pharma is an active private limited company based in Bathinda, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 April 2023 (3+ years old) and is registered under CIN U46497PB2023PTC058130.
Avosia Pharma reported revenue of ₹1.9 Cr for FY 2025 (up 247% YoY).
Avosia Pharma has 2 current directors:
- Neelam Rani - Additional Director
- Jagjit Kumar - Director
Avosia Pharma reported a net profit of ₹60,848 (net margin 0.3%) and EBITDA of ₹6.1 Lakh (EBITDA margin 3.2%) for FY 2025, as per its filed financial statements.
The GSTIN of Avosia Pharma is 06AAYCA4970C1ZF, registered in Haryana.
The CIN (Corporate Identification Number) of Avosia Pharma is U46497PB2023PTC058130. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avosia Pharma was incorporated on 10 April 2023, making it 3+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Avosia Pharma by revenue are Phenomenon Nutritech Private Limited, Zenith Chemical Works Private Limited, Rege Engredea Private Limited, Kan India Realtors Private Limited, Laurel Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Neelam Rani was appointed as Additional Director on 08 Dec 2023. Romi Bansal ceased to be Director on 08 Dec 2023. Jagjit Kumar was appointed as Director on 10 Apr 2023.
The registered office of Avosia Pharma is at F – 102 Industrial Growth Centre, Mansa Road, Bathinda, Punjab, India – 151001.
Avosia Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.